Digital Look

Silence Therapeutics (SLN)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE AIM All-Share

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

1.58p

Change Today:

0.11p
52 Week High: 3.30p
52 Week Low: 1.47p

Currency: UK Pounds
Shares Issued: 577.11m
Volume: 240,000

Market Cap: £9.09m
RiskGrade: 317
Beta: 0.74

Update - Silence Therapeutics is rising today - learn to spread bet rising stocks Find out more
Update -Silence Therapeutics is a top riser in its sector - discover how to spread bet similar stocks Find out more

SLN Overview

Silence Therapeutics is in the pharmaceuticals & biotechnology sector and is currently trading at 1.58p per share. In the last year Silence Therapeutics's share price has ranged from 1.47p to 3.30p.

1 Day Chart

6 Month Chart

More Silence Therapeutics charts

Financials

	Latest	F'cast
Div Yield	0.0%	0.0%
Div Cover	n/a	n/a
Op Mrgn	-834.2%	46.2%
ROCE	n/a

	Latest	F'cast
P/E	n/a	1.8
PEG	n/a	n/a
Pr/Revenue	13.1	0.8
Pr/Book	0.3

	Latest	F'cast
Revenue	-70.7%	1587.0%
PBT	n/a	n/a
EPS	n/a	n/a
DPS	n/a	n/a

SLN Fundamentals

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-07	4.05	(5.24)	(4.17)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-08	2.21	(7.43)	(5.88)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-09	1.72	(7.51)	(5.27)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-10	2.37	(8.80)	(3.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-11	0.69	(5.74)	(1.10)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SLN Forecasts

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-12	11.70	5.40	0.90p	1.8	n/a	n/a	n/a	0.0%
31-Dec-13	8.90	2.40	0.40p	3.9	n/a	-56%	n/a	0.0%

Silence Therapeutics forecasts

SLN Company Announcements

New data from Phase I trial with Atu027	17-May-2012	07:00	PR Newswire
Publication of 2011 Annual Report and Notice of ...	14-May-2012	07:00	PR Newswire
Silence Therapeuticsâ€™ Partner extends agreement	03-May-2012	07:00	PR Newswire

More Silence Therapeutics sln company announcements

SLN ShareCast News

Silence Therapeutics lands new partnership	27-Sep-2011	ShareCast
Silence losses grow despite higher revenues	27-Apr-2011	ShareCast
Silence boosted by partner's test results	21-Mar-2011	ShareCast

More Silence Therapeutics ShareCast news

SLN Top Newspaper Links

Need to know: Carlsberg ... Sony Ericsson ... Ar...	18-Oct-2008	Times
Database	24-Jun-2006	Telegraph
Failure to deliver hits drugs company shareholders	12-Apr-2001	The Scotsman

Latest SLN Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

SLN Market Data

Currency	UK Pounds
Share Price	1.58p
Change Today	0.11p
% Change	7.51 %
52 Week High	3.30p
52 Week Low	1.47p
Volume	240,000
Shares Issued	577.11m
Market Cap	£9.09m
Beta	0.74
RiskGrade	317